Navigation Links
Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate
Date:3/23/2011

reatment. Patients were randomized (1:1) to receive either Prolia every six months in year 1 followed by weekly oral alendronate in year 2, or receive alendronate in year 1 followed by Prolia in year 2.

In the study, 92.4 percent of the patients preferred Prolia over alendronate versus 7.6 percent who preferred alendronate (p<0.0001). Additionally, 91.2 percent preferred Prolia as a treatment option versus 8.8 percent for alendronate (p<0.0001), and overall significantly more patients were more satisfied with treatment with Prolia compared to treatment with oral alendronate.

In patients who received Prolia in the second year of the study, treatment with Prolia compared to alendronate was associated with significantly greater:

  • adherence (92.5 percent vs. 63.5 percent, p<0.0001),
  • compliance (93.4 percent vs. 67.8 percent, p<0.0001), and
  • persistence (97.2 percent vs. 71.3 percent, p<0.0001) with treatment.

  • Patients were considered adherent to treatment if they received two Prolia injections within 6 months (plus or minus 4 weeks) apart, or took greater than or equal to 80 percent weekly oral alendronate and at least two alendronate tablets in the last month, and returned for the final study visit within an allotted time.

    The incidence and types of adverse events (AEs) and serious adverse events (SAEs) were generally similar between the Prolia and alendronate patient groups. SAEs were reported in 3.5 percent and 3.9 percent of patients receiving Prolia and alendronate, respectively.

    Osteoporosis: Impact, Prevalence and the Role of AdherenceReferred to as a "silent epidemic" by the International Osteoporosis Foundation (IOF), osteoporosis is a global problem that is increasing in significance as the population of the world both increases and ages. The World Health Organization has officially declared osteoporosis a public health crisis, and the IOF is urging governments worldwide to
    '/>"/>

    SOURCE Amgen
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Five Years of Treatment With Similar Safety Profile Observed in Pivotal Trial
    2. Study Demonstrates Relationship Between Subcutaneous IgG (SCIg) Dosage and Clinical Outcomes With Hizentra® Treatment in Patients With Primary Immunodeficiencies
    3. AstraZeneca Initiates Phase III Clinical Programme Evaluating NKTR-118 for Treatment of Opioid-Induced Constipation
    4. Optimer Pharmaceuticals Announces Issuance of Key Patent Covering Fidaxomicin Methods of Use as a Treatment of Clostridium difficile infection
    5. The Balance-Based Torso-Weighting® Treatment for Multiple Sclerosis Receives a NIH Recovery Act Grant
    6. Los Angeles Dentist, Dr. Kevin Sands, Uses the Latest Technologies to Provide VIP Services and Treatments for His Patients
    7. International Prostate Cancer Treatment Expert Dr. David B. Samadi Supports Kenyan Minister of Medical Services, Peter Anyang Nyongos Decision to Travel to the U.S. for Prostate Cancer Treatment
    8. Practice Guidelines Confirm Utility of Endoscopic Radiofrequency Ablation (RFA) for the Treatment of Barretts Esophagus
    9. Pew Applauds Introduction of Preservation of Antibiotics for Medical Treatment Act of 2011
    10. Tris Announces NDA Acceptance of Extended Release Carbinoxamine Oral Suspension for the Treatment of Allergies in Kids Two Years and Older
    11. Genus Oncology, LLC Announces Orphan Drug Status for GO-203-2c for Treatment of Pancreatic Cancer
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... Markets ( http://www.researchandmarkets.com/research/5dh22x/urinary_catheters ) has announced the ... Foley Catheters, Intermittent Catheters and Male External or Condom ... and Forecast 2014 - 2020" report to their ... market for urinary catheters is experiencing a healthy growth ...
    (Date:1/23/2015)... , Jan. 23, 2015 More than a third ... quarter of those with private insurance, filled a prescription for ... a report in this week,s Morbidity and Mortality Weekly Report ... care providers to treat moderate to severe pain.  They are ...
    (Date:1/23/2015)... , Jan. 23, 2015  Now available for sale, The ... support that prevents ankle sprains by cushioning the ankle ... fits securely around the outside of any shoe type ... comfort while still offering protection against sprains. With customers ...
    Breaking Medicine Technology:Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2
    ... Nov. 14, 2011 Regado Biosciences, Inc., a privately ... with active control agents, announces one poster presentation ... Association (AHA) Scientific Sessions meeting on November 14, ... EST session.  All three presentations highlight results from ...
    ... Corporation ("the Company"), a leading international manufacturer, marketer, and ... today announced its 2011 third quarter financial results. ... For the third quarter of 2011, the ... of 7.8% versus net sales of $223.7 million in ...
    Cached Medicine Technology:Regado Biosciences, Inc. Presents Three Abstracts Pertaining to its Pipeline of Reversible Antithrombotic Agents, Including the Substudy Analyses of its Phase 2b RADAR Trial for REG1, its Lead Product Candidate, at the American Heart Association (AH 2Regado Biosciences, Inc. Presents Three Abstracts Pertaining to its Pipeline of Reversible Antithrombotic Agents, Including the Substudy Analyses of its Phase 2b RADAR Trial for REG1, its Lead Product Candidate, at the American Heart Association (AH 3Regado Biosciences, Inc. Presents Three Abstracts Pertaining to its Pipeline of Reversible Antithrombotic Agents, Including the Substudy Analyses of its Phase 2b RADAR Trial for REG1, its Lead Product Candidate, at the American Heart Association (AH 4Pregis Announces Third Quarter 2011 Financial Results 2Pregis Announces Third Quarter 2011 Financial Results 3Pregis Announces Third Quarter 2011 Financial Results 4Pregis Announces Third Quarter 2011 Financial Results 5Pregis Announces Third Quarter 2011 Financial Results 6Pregis Announces Third Quarter 2011 Financial Results 7Pregis Announces Third Quarter 2011 Financial Results 8Pregis Announces Third Quarter 2011 Financial Results 9Pregis Announces Third Quarter 2011 Financial Results 10Pregis Announces Third Quarter 2011 Financial Results 11Pregis Announces Third Quarter 2011 Financial Results 12
    (Date:1/22/2015)... 2015 For over 20 years, Dr. David Cruz ... Vista area has treated just about every type of injury ... And for those same twenty-plus years, the team at ... injuries with the best possible doctor. With the combined ...
    (Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 ... College of Sports Medicine flagship journal Medicine & ... with L-Citrulline before exercise may help reduce gastrointestinal ... exercise. 1 , Participants in the double-blind, ...
    (Date:1/22/2015)... IsoComforter, Inc. has introduced the most innovative ... design to treat specific body parts and muscle groups. , ... easy to use patented cold therapy machine with the innovative ... and muscle injuries. IsoComforter has become the industry leader ...
    (Date:1/22/2015)... Mass. (PRWEB) January 22, 2015 EBSCO ... (AMA) are expanding their relationship in an effort to ... around the world. While EBSCO has long made AMA journals ... a sales agent for The JAMA Network. , ...
    (Date:1/22/2015)... Compare-autoinsurance.org has released a new blog post presenting a ... insurance policy . , Some types of vehicles cannot be ... newly released blog post to see if their vehicle qualifies for ... are some of the cars that cannot be covered by a ...
    Breaking Medicine News(10 mins):Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2
    ... study conducted by the British scientist it was found that ... cell divides.// ,Hence it is thought that the ... The study compared the length of telomeres of 1,552 female ... The participants were also adjusted for other factors such as ...
    ... could cause a change in the role of district nurses.// ... roles of community health professionals such as health visitors and ... about 9,000 nurses across Scotland. ,These were the ... major review of the community health sector for the health ...
    ... miss the court session of his trial Monday due to ... strike, a court// source said. ,"Saddam will not ... after he was hospitalised for mounting a hunger strike for ... Court told Deutsche Presse-Agentur (DPA) on Monday. ,The ...
    ... Pradesh to impart sex education to girl students of ... ,The state government had selected Mainpuri and Allahabad ... will be educated about the HIV/AIDS and other sex-related ... held apart from distribution of study material to the ...
    ... reduce maternal mortality ratio in the state, Rajasthan has decided to ... of such deaths. ,The maternal mortality ratio (MMR) ... 100,000 live births and is a measure of the death of ... in Rajasthan is much above the national average of 407. Owing ...
    ... people living with HIV/AIDS in the country do not ... Nations study has said. // ,"Seventy-four per ... status at their workplace. Of the remaining 26 per ... have reported facing discrimination at the hands of the ...
    Cached Medicine News:Health News:Rajasthan to Conduct Audit to Find Out the Cause of Maternal Mortality 2
    ... Bio-Dot SF (slot format) microfiltration units provide ... nucleic acid in solution onto nitrocellulose or ... accommodated by using interchangeable templates to form ... format Bio-Dot SF apparatus. Each is available ...
    ... Disposable, clear, APET plastic tray. Small ... includes stickers to identify those trays used ... facilitate pouring off liquid. A marker or ... is designed for stacking trays on rockers ...
    ... porous vacuum plate, reservoir seal O-ring, sealing frame, ... 785 vacuum blotter quickly and efficiently transfers DNA ... nylon membrane. Because it generally requires only 90 ... be separated on a gel, transferred to a ...
    ... Includes vacuum pump, vacuum regulator. The ... transfers DNA or RNA from an agarose ... generally requires only 90 min for transfer, ... on a gel, transferred to a membrane, ...
    Medicine Products: